Variant report
Variant | esv2760288 |
---|---|
Chromosome Location | chr11:106214708-106238708 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs17105543 | chr11:106214708-106214709 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs17105544 | chr11:106214768-106214769 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs575333708 | chr11:106214817-106214818 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs546030789 | chr11:106214821-106214822 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs189122681 | chr11:106214840-106214841 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs572991495 | chr11:106214845-106214846 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs150794647 | chr11:106214871-106214872 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs115651690 | chr11:106214892-106214893 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs529315566 | chr11:106214908-106214909 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs544323835 | chr11:106215007-106215008 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs562498865 | chr11:106215066-106215067 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs534285384 | chr11:106215080-106215081 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs11822205 | chr11:106215117-106215118 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs143975284 | chr11:106215128-106215129 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs145944774 | chr11:106215145-106215146 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs549345161 | chr11:106215155-106215156 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs1396160 | chr11:106215204-106215205 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs535513285 | chr11:106215212-106215213 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs187185259 | chr11:106215251-106215252 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs563533734 | chr11:106215266-106215267 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs568861844 | chr11:106215308-106215309 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs1396159 | chr11:106215352-106215353 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
23 | rs11827231 | chr11:106215371-106215372 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs560782591 | chr11:106215387-106215388 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs74497668 | chr11:106215442-106215443 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs540538628 | chr11:106215466-106215467 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs555116743 | chr11:106215498-106215499 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs527961064 | chr11:106215645-106215646 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs139844817 | chr11:106215655-106215656 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs190507101 | chr11:106215686-106215687 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs181676328 | chr11:106215804-106215805 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs577965483 | chr11:106215816-106215817 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs545098364 | chr11:106215858-106215859 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs149693649 | chr11:106215881-106215882 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs527943543 | chr11:106215933-106215934 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs375821597 | chr11:106215964-106215965 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs116368886 | chr11:106216017-106216018 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs35782179 | chr11:106216023-106216024 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs545530795 | chr11:106216029-106216030 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs186021059 | chr11:106216043-106216044 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs531950607 | chr11:106216085-106216086 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs80023452 | chr11:106216101-106216102 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs569002062 | chr11:106216138-106216139 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs539404516 | chr11:106216150-106216151 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs190392144 | chr11:106216161-106216162 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs181248677 | chr11:106216163-106216164 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs79175768 | chr11:106216356-106216357 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs186276369 | chr11:106216418-106216419 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs574148140 | chr11:106216466-106216467 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs10750753 | chr11:106216467-106216468 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Gastric cancer | 17908304 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Wilms tumour | 21544195 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Cancer | 21637783 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Chronic lymphocytic leukemia | 21795749 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 20837533 | CNVD |
Breast cancer | 21264507 | CNVD |
Cervical cancer | 21063398 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Liposarcoma | 21253554 | CNVD |
Neuroblastoma | 18923524 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Cancer | 16751803 | CNVD |
Seminomas | 18059402 | CNVD |
Cervical cancer | 21062161 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 22429812 | CNVD |
Breast cancer | 16608533 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Hepatocellular carcinoma | 16785998 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 21858162 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 21958427 | CNVD |
Lung cancer | 18438408 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Breast cancer | 17133270 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 17603634 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Basal cell lymphoma | 16790693 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Breast cancer | 21364760 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Mental retardation | 19966786 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Ovine squamous-cell carcinoma | 17599052 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Chronic lymphocytic leukemia | 17805327 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Breast cancer | 16397240 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Neuroblastoma | 17327916 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Mantle cell lymphoma | 19029149 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Malignant melanoma | 17260012 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Prostate cancer | 16573809 | CNVD |
Obesity | 19966786 | CNVD |
Prostate cancer | 18632612 | CNVD |
Melanoma | 17363583 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Cancer | 20164919 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:106214200-106215600 | Enhancers | Fetal Brain Female | brain |
2 | chr11:106214400-106215400 | Enhancers | Fetal Brain Male | brain |
3 | chr11:106214600-106215400 | Enhancers | Brain Dorsolateral Prefrontal Cortex | brain |
4 | chr11:106214800-106215600 | Enhancers | Fetal Intestine Large | intestine |
5 | chr11:106214800-106215600 | Enhancers | Fetal Intestine Small | intestine |
6 | chr11:106215000-106215400 | Enhancers | Foreskin Fibroblast Primary Cells skin01 | Skin |
7 | chr11:106215000-106215600 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
8 | chr11:106215000-106215600 | Enhancers | Muscle Satellite Cultured Cells | -- |
9 | chr11:106215200-106215600 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
10 | chr11:106215200-106215600 | Enhancers | Cortex derived primary cultured neurospheres | brain |
11 | chr11:106215200-106215600 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
12 | chr11:106215200-106215600 | Enhancers | NHLF | lung |
13 | chr11:106215400-106216400 | Weak transcription | Fetal Brain Male | brain |
14 | chr11:106216400-106216800 | Enhancers | Fetal Brain Male | brain |
15 | chr11:106232600-106235400 | Weak transcription | Pancreas | Pancrea |
16 | chr11:106234600-106235600 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
17 | chr11:106235600-106239000 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
18 | chr11:106237600-106240200 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
19 | chr11:106237600-106240600 | Enhancers | NHEK | skin |
20 | chr11:106238000-106240200 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
21 | chr11:106238400-106241200 | Enhancers | NHDF-Ad | bronchial |
22 | chr11:106238600-106239200 | Enhancers | Foreskin Fibroblast Primary Cells skin01 | Skin |
23 | chr11:106238600-106240600 | Enhancers | HMEC | breast |
24 | chr11:106238600-106240800 | Enhancers | Muscle Satellite Cultured Cells | -- |
25 | chr11:106238600-106241200 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |